Clinical Trials Directory

Trials / Conditions / Hemoglobinopathy

Hemoglobinopathy

8 registered clinical trials studyying Hemoglobinopathy — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Long-term Follow-up Study in Patients Who Received BEAM-101
NCT07373639
Beam Therapeutics Inc.—
RecruitingA Phase I Study of SNH-119014 in Healthy Volunteers
NCT07087262
ScinnoHub Pharmaceutical Co., Ltd.Phase 1
RecruitingDetermination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
NCT06313398
National Heart, Lung, and Blood Institute (NHLBI)EARLY_Phase 1
TerminatedT-cell Depleted Alternative Donor Transplantation
NCT00968864
Wake Forest University Health SciencesPhase 2
TerminatedBone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
NCT00040417
Baylor College of MedicinePhase 2
TerminatedBone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
NCT00040469
Baylor College of MedicinePhase 2
CompletedHydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
No Longer AvailableExpanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Trans
NCT01200017
Christopher Dvorak—